Related Experiment Video

Updated: May 26, 2026

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs

Nazia N Choudhury1, Huixin He

  • 1Department of Chemistry, Rutgers, State University of New Jersey, Newark, USA.

Current Pharmaceutical Biotechnology
|December 29, 2011
PubMed

Insights

Advanced nanocarriers enable simultaneous delivery of genes and drugs for combination cancer therapy. This approach aims to improve treatment efficacy and reduce side effects by precisely targeting cancer cells.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Cancer's molecular complexity necessitates combination therapies for improved outcomes and reduced side effects.
  • Advanced drug delivery systems (DDSs) are crucial for co-delivering multiple agents with controlled release.
  • Nanocarriers for combined chemical drugs are well-established; this review focuses on gene-drug combinations.

Purpose of the Study:

  • To review nanotechnology-enabled DDSs for simultaneous co-delivery of therapeutic genes and chemical drugs in cancer treatment.
  • To discuss the potential opportunities and inherent challenges of this combined therapeutic strategy.

Main Methods:

  • Literature review focusing on nanotechnology-based drug delivery systems.
  • Analysis of studies involving simultaneous co-delivery of genes and chemical drugs for cancer.
  • Discussion of the strategic advantages and limitations of combined gene-chemical drug delivery.

Main Results:

  • Nanotechnology offers advanced DDSs for precise, simultaneous delivery of multiple therapeutic agents.
  • Co-delivery of genes and chemical drugs via nanocarriers presents a promising strategy for enhanced cancer therapy.
  • Challenges include optimizing delivery, controlling release kinetics, and ensuring synergistic effects.

Conclusions:

  • Nanotechnology-enabled DDSs are pivotal for advancing combination cancer therapy through simultaneous gene and chemical drug delivery.
  • This integrated approach holds significant promise for improving long-term prognosis and minimizing adverse effects in cancer patients.
  • Further research is needed to overcome challenges and fully realize the therapeutic potential of combined gene-drug nanodelivery systems.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...